Yiling Lu

Professor

  • 35641 Citations
  • 73 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yiling Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Neoplasms Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Protein Array Analysis Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Proteomics Medicine & Life Sciences
Mutation Medicine & Life Sciences
Phosphorylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (Nature Communications, (2018), 9, 1, (5426), 10.1038/s41467-018-07126-9)

Liu, S., Zhang, G., Guo, J., Chen, X., Lei, J., Ze, K., Dong, L., Dai, X., Gao, Y., Song, D., Ecker, B. L., Yang, R., Feltcher, C., Peng, K., Feng, C., Chen, H., Lee, R. X., Kerestes, H., Niu, J., Kumar, S. & 15 others, Xu, W., Zhang, J., Wei, Z., Martin, J. S., Liu, X., Mills, G. B., Lu, Y., Guo, W., Sun, L., Zhang, L., Weeraratna, A., Herlyn, M., Wei, W., Lee, F. S. & Xu, X., Dec 1 2019, In : Nature communications. 10, 1, 1211.

Research output: Contribution to journalComment/debate

Open Access
document markup languages
HTML
communication
Communication

CD44 expression predicts prognosis of ovarian cancer patients through promoting epithelial-mesenchymal transition (EMT) by regulating snail, ZEB1, and caveolin-1

Zhou, J., Du, Y., Lu, Y., Luan, B., Xu, C., Yu, Y. & Zhao, H., Jan 1 2019, In : Frontiers in Oncology. 9, AUG, 802.

Research output: Contribution to journalArticle

Open Access
Caveolin 1
Epithelial-Mesenchymal Transition
Snails
Ovarian Neoplasms
Disease-Free Survival
1 Citation (Scopus)

Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer

Li, X., Mak, V. C. Y., Zhou, Y., Wang, C., Wong, E. S. Y., Sharma, R., Lu, Y., Cheung, A. N. Y., Mills, G. B. & Cheung, L. W. T., Dec 1 2019, In : Nature communications. 10, 1, 716.

Research output: Contribution to journalArticle

Open Access
phosphorylation
Phosphorylation
Ovarian Neoplasms
cancer
Tumors

Erratum to: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (Nature, (2017), 10.1038/nature24040)

Lu, H., Liu, S., Zhang, G., Wu, B., Zhu, Y., Frederick, D. T., Hu, Y., Zhong, W., Randell, S., Sadek, N., Zhang, W., Chen, G., Cheng, C., Zeng, J., Wu, L. W., Zhang, J., Liu, X., Xu, W., Krepler, C., Sproesser, K. & 21 others, Xiao, M., Miao, B., Liu, J., Song, C. D., Liu, J. Y., Karakousis, G. C., Schuchter, L. M., Lu, Y., Mills, G. B., Cong, Y., Chernoff, J., Guo, J., Boland, G. M., Sullivan, R. J., Wei, Z., Field, J., Amaravadi, R. K., Flaherty, K. T., Herlyn, M., Xu, X. & Guo, W., Jan 10 2019, In : Nature. 565, 7738, p. E4

Research output: Contribution to journalComment/debate

Drug Resistance
Melanoma

Identification and validation of a prognostic proteomic signature for cervical cancer

Rader, J. S., Pan, A., Corbin, B., Iden, M., Lu, Y., Vellano, C. P., Akbani, R., Mills, G. B. & Simpson, P., Jan 1 2019, (Accepted/In press) In : Gynecologic oncology.

Research output: Contribution to journalArticle

Uterine Cervical Neoplasms
Proteomics
Atlases
Protein Array Analysis
Genome